Publikationen in Zusammenarbeit mit Forschern von University Hospital of Bern (5)

2018

  1. Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial

    The Lancet Oncology, Vol. 19, Núm. 1, pp. 127-138

  2. Tailoring adjuvant endocrine therapy for premenopausal breast cancer

    New England Journal of Medicine, Vol. 379, Núm. 2, pp. 122-137

2016

  1. Adjuvant tamoxifen plus ovarian function suppression versus tamoxifen alone in premenopausal women with early breast cancer: Patient-reported outcomes in the suppression of ovarian function trial

    Journal of Clinical Oncology, Vol. 34, Núm. 14, pp. 1601-1610

2015

  1. Adjuvant ovarian suppression in premenopausal breast cancer

    New England Journal of Medicine, Vol. 372, Núm. 5, pp. 436-446

2014

  1. Adjuvant exemestane with ovarian suppression in premenopausal breast cancer

    New England Journal of Medicine, Vol. 371, Núm. 2, pp. 107-118